Skip to main content
SpringerLink
Log in
Book cover

Disorders of Thrombosis and Hemostasis in Pregnancy pp 185–195Cite as

The Management and Outcome of Pregnancy in Patients with Myeloproliferative Neoplasms

  • Chapter
  • First Online:

  • 990 Accesses

Abstract

The myeloproliferative neoplasms are rare blood cancers which are characterised by increased risks of thrombosis, haemorrhage and also risk of transformation to acute myeloid leukaemia. These conditions are common in older adults but they do occur in children and young adults and as a consequence fertility and management of pregnancy is an issue for patients with these conditions. In this chapter we shall briefly review the pathogenesis of MPN before describing what is known about pregnancy outcomes for these patients and presenting an algorithm for pregnancy management.

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   169.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

References

  1. Barbui T, Finazzi G. Myeloproliferative disease in pregnancy and other management issues. Hematology Am Soc Hematol Educ Program. 2006;246–52.

    Google Scholar 

  2. Baxter EJ, Scott LM, Campbell PJ, East C, Fourouclas N, Swanton S, Vassiliou GS, Bench AJ, Boyd EM, Curtin N, Scott MA, Erber WN, Green AR. Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders. Lancet. 2005;365:1054–61.

    PubMed  CAS  Google Scholar 

  3. Bayley D, Temple C, Clay V, Steward A, Lowther N. The transmucosal absorption of recombinant human interferon-alpha B/D hybrid in the rat and rabbit. J Pharm Pharmacol. 1995;47:721–4.

    Article  PubMed  CAS  Google Scholar 

  4. Ding J, Komatsu H, Wakita A, Kato-Uranishi M, Ito M, Satoh A, Tsuboi K, Nitta M, Miyazaki H, Iida S, Ueda R. Familial essential thrombocythemia associated with a dominant-positive activating mutation of the c-MPL gene, which encodes for the receptor for thrombopoietin. Blood. 2004;103:4198–200.

    Article  PubMed  CAS  Google Scholar 

  5. Fritz M, Vats K, Goyal RK. Neonatal lupus and IUGR following alpha-interferon therapy during pregnancy. J Perinatol. 2005;25:552–4.

    Article  PubMed  Google Scholar 

  6. Gangat N, Wolanskyj AP, Schwager S, Tefferi A. Predictors of pregnancy outcome in essential thrombocythemia: a single institution study of 63 pregnancies. Eur J Haematol. 2009;82:350–3.

    Article  PubMed  Google Scholar 

  7. Gangat N, Wolanskyj AP, Schwager SM, Mesa RA, Tefferi A. Estrogen-based hormone therapy and thrombosis risk in women with essential thrombocythemia. Cancer. 2006;106:2406–11.

    Article  PubMed  CAS  Google Scholar 

  8. Greer IA, Nelson-Piercy C. Low-molecular-weight heparins for thromboprophylaxis and treatment of venous thromboembolism in pregnancy: a systematic review of safety and efficacy. Blood. 2005;106:401–7.

    Article  PubMed  CAS  Google Scholar 

  9. Griesshammer M, Bergmann L, Pearson T. Fertility, pregnancy and the management of myeloproliferative disorders. Baillieres Clin Haematol. 1998;11:859–74.

    Article  PubMed  CAS  Google Scholar 

  10. Harrison CN. Essential thrombocythaemia: challenges and evidence-based management. Br J Haematol. 2005;130:153–65.

    Article  PubMed  Google Scholar 

  11. Harrison C. Pregnancy and its management in the Philadelphia negative myeloproliferative diseases. Br J Haematol. 2005;129:293–306.

    Article  PubMed  CAS  Google Scholar 

  12. James C, Ugo V, Le Couedic JP, Staerk J, Delhommeau F, Lacout C, Garcon L, Raslova H, Berger R, Bennaceur-Griscelli A, Villeval JL, Constantinescu SN, Casadevall N, Vainchenker W. A unique clonal JAK2 mutation leading to constitutive signalling causes polycythaemia vera. Nature. 2005;434:1144–8.

    Article  PubMed  CAS  Google Scholar 

  13. Jones AV, Chase A, Silver RT, Oscier D, Zoi K, Wang YL, Cario H, Pahl HL, Collins A, Reiter A, Grand F, Cross NC. JAK2 haplotype is a major risk factor for the development of myeloproliferative neoplasms. Nat Genet. 2009;41:446–9.

    Article  PubMed  CAS  Google Scholar 

  14. Royal College of Obstetricians and Gynaecologists. Air travel and pregnancy. Scientific Advisory Commit-tee Opinion Paper 1. London: RCOG Press; 2008.

    Article  PubMed  CAS  Google Scholar 

  15. Kiladjian JJ, Cassinat B, Chevret S, Turlure P, Cambier N, Roussel M, Bellucci S, Grandchamp B, Chomienne C, Fenaux P. Pegylated interferon-alfa-2a induces complete hematologic and molecular responses with low toxicity in polycythemia vera. Blood. 2008;112:3065–72.

    Article  PubMed  CAS  Google Scholar 

  16. Kilpivaara O, Mukherjee S, Schram AM, Wadleigh M, Mullally A, Ebert BL, Bass A, Marubayashi S, Heguy A, Garcia-Manero G, Kantarjian H, Offit K, Stone RM, Gilliland DG, Klein RJ, Levine RL. A germline JAK2 SNP is associated with predisposition to the development of JAK2(V617F)-positive myeloproliferative neoplasms. Nat Genet. 2009;41:455–9.

    Article  PubMed  CAS  Google Scholar 

  17. Kralovics R, Passamonti F, Buser AS, Teo SS, Tiedt R, Passweg JR, Tichelli A, Cazzola M, Skoda RC. A gain-of-function mutation of JAK2 in myeloproliferative disorders. N Engl J Med. 2005;352:1779–90.

    Article  PubMed  CAS  Google Scholar 

  18. Kumar AR, Hale TW, Mock RE. Transfer of interferon alfa into human breast milk. J Hum Lact. 2000;16:226–8.

    Article  PubMed  CAS  Google Scholar 

  19. Landgren O, Goldin LR, Kristinsson SY, Helgadottir EA, Samuelsson J, Bjorkholm M. Increased risks of polycythemia vera, essential thrombocythemia, and myelofibrosis among 24,577 first-degree relatives of 11,039 patients with myeloproliferative neoplasms in Sweden. Blood. 2008;112:2199–204.

    Article  PubMed  CAS  Google Scholar 

  20. Levine RL, Wadleigh M, Cools J, Ebert BL, Wernig G, Huntly BJ, Boggon TJ, Wlodarska I, Clark JJ, Moore S, Adelsperger J, Koo S, Lee JC, Gabriel S, Mercher T, D’Andrea A, Frohling S, Dohner K, Marynen P, Vandenberghe P, Mesa RA, Tefferi A, Griffin JD, Eck MJ, Sellers WR, Meyerson M, Golub TR, Lee SJ, Gilliland DG. Activating mutation in the tyrosine kinase JAK2 in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosis. Cancer Cell. 2005;7:387–97.

    Article  PubMed  CAS  Google Scholar 

  21. Liebelt EL, Balk SJ, Faber W, Fisher JW, Hughes CL, Lanzkron SM, Lewis KM, Marchetti F, Mehendale HM, Rogers JM, Shad AT, Skalko RG, Stanek EJ. NTP-CERHR expert panel report on the reproductive and developmental toxicity of hydroxyurea. Birth Defects Res B Dev Reprod Toxicol. 2007;80:259–366.

    Article  PubMed  CAS  Google Scholar 

  22. Olcaydu D, Harutyunyan A, Jager R, Berg T, Gisslinger B, Pabinger I, Gisslinger H, Kralovics R. A common JAK2 haplotype confers susceptibility to myeloproliferative neoplasms. Nat Genet. 2009;41:450–4.

    Article  PubMed  CAS  Google Scholar 

  23. Passamonti F, Randi ML, Rumi E, Pungolino E, Elena C, Pietra D, Scapin M, Arcaini L, Tezza F, Moratti R, Pascutto C, Fabris F, Morra E, Cazzola M, Lazzarino M. Increased risk of pregnancy complications in patients with essential thrombocythemia ­carrying the JAK2 (617V>F) mutation. Blood. 2007;110:485–9.

    Article  PubMed  CAS  Google Scholar 

  24. Patel RK, Lea NC, Heneghan MA, Westwood NB, Milojkovic D, Thanigaikumar M, Yallop D, Arya R, Pagliuca A, Gaken J, Wendon J, Heaton ND, Mufti GJ. Prevalence of the activating JAK2 tyrosine kinase mutation V617F in the Budd-Chiari syndrome. Gastroenterology. 2006;130:2031–8.

    Article  PubMed  CAS  Google Scholar 

  25. Pikman Y, Lee BH, Mercher T, McDowell E, Ebert BL, Gozo M, Cuker A, Wernig G, Moore S, Galinsky I, DeAngelo DJ, Clark JJ, Lee SJ, Golub TR, Wadleigh M, Gilliland DG, Levine RL. MPLW515L Is a novel somatic activating mutation in myelofibrosis with myeloid metaplasia. PLoS Med. 2006;3:e270.

    Article  PubMed  Google Scholar 

  26. Robinson S, Bewley S, Hunt BJ, Radia DH, Harrison CN. The management and outcome of 18 pregnancies in women with polycythemia vera. Haematologica. 2005;90:1477–83.

    PubMed  Google Scholar 

  27. Scott LM, Tong W, Levine RL, Scott MA, Beer PA, Stratton MR, Futreal PA, Erber WN, McMullin MF, Harrison CN, Warren AJ, Gilliland DG, Lodish HF, Green AR. JAK2 exon 12 mutations in polycythemia vera and idiopathic erythrocytosis. N Engl J Med. 2007;356:459–68.

    Article  PubMed  CAS  Google Scholar 

  28. Swerdlow SH. WHO classification of tumours of ­haematopoietic and lymphoid tissues – IARC WHO classification of tumours v. 2. 2nd ed. Geneva: World Health Organization; 2008.

    Google Scholar 

  29. Tulpule S, Bewley S, Robinson SE, Radia D, Nelson-Piercy C, Harrison CN. The management and outcome of four pregnancies in women with idiopathic myelofibrosis. Br J Haematol. 2008;142:480–2.

    Article  PubMed  Google Scholar 

  30. Wiestner A, Schlemper RJ, van der Maas AP, Skoda RC. An activating splice donor mutation in the thrombopoietin gene causes hereditary thrombocythaemia. Nat Genet. 1998;18:49–52.

    Article  PubMed  CAS  Google Scholar 

  31. Willoughby SJ, Fairhead S, Woodcock BE, Pearson TC. Postpartum thrombosis in primary thrombocythaemia. Eur J Haematol. 1997;59:121–3.

    Article  PubMed  CAS  Google Scholar 

  32. Royal College of Obstetricians and Gynaecologists. Green-top guideline no. 37. Thrombosis and embolism during pregnancy and the puerperium, Reducing the risk. 2009.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Haematology, Guy’s and St Thomas’ NHS Foundation Trust, Guy’s Hospital, London, UK

    Susan E. Robinson BMBCh, M.Sc., MRCP, FRCPath & Claire N. Harrison DM, FRCP, FRCPath

Authors
  1. Susan E. Robinson BMBCh, M.Sc., MRCP, FRCPath
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Claire N. Harrison DM, FRCP, FRCPath
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Claire N. Harrison DM, FRCP, FRCPath .

Editor information

Editors and Affiliations

  1. Aberdare Gardens 36, London, NW6 3QA, United Kingdom

    Hannah Cohen

  2. Dept. Obstetrics & Gynaecology, University College Hospital, Chenies Mews 86-96, London, WC1E 6HX, United Kingdom

    Patrick O'Brien

Rights and permissions

Reprints and permissions

Copyright information

© 2012 Springer-Verlag London

About this chapter

Cite this chapter

Robinson, S.E., Harrison, C.N. (2012). The Management and Outcome of Pregnancy in Patients with Myeloproliferative Neoplasms. In: Cohen, H., O'Brien, P. (eds) Disorders of Thrombosis and Hemostasis in Pregnancy. Springer, London. https://doi.org/10.1007/978-1-4471-4411-3_13

Download citation

  • DOI: https://doi.org/10.1007/978-1-4471-4411-3_13

  • Published:

  • Publisher Name: Springer, London

  • Print ISBN: 978-1-4471-4410-6

  • Online ISBN: 978-1-4471-4411-3

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation